#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	1670	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2045	152.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1391	1391	C	183	C	116	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2788	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3781	133.6	0	.	n	.	0	T695C	SNP	695	695	T	1098	1098	C	191	C	112	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2788	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3781	133.6	0	.	n	.	0	G1337A	SNP	1337	1337	G	1740	1740	A	111	A	66	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2788	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3781	133.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2374	2374	C	117	C	69	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2788	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3781	133.6	1	SNP	n	A2045G	1	A2045G	SNP	2045	2045	A	2448	2448	G	126	G,T	72,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	2788	23S	2890	2890	99.86	23S.l15.c4.ctg.1	3781	133.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3000	3000	C	183	C	111	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	539	19068	blaTEM	861	861	99.88	blaTEM.l15.c17.ctg.1	1533	2190.2	0	.	p	.	0	M180T	NONSYN	538	540	ATG	946	948	ACG	3092;3096;3084	A,G,C,T;C,A,T;G,T	1808,1,1,1;1848,2,1;1842,4	.	Betalactam resistance
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	114	folP	855	855	99.88	folP.l6.c17.ctg.1	1093	17.3	1	SNP	p	R229S	1	.	.	685	687	AGC	731	733	AGC	16;16;16	A;G;C	9;9;9	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	300	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3053	18.6	0	.	p	.	0	G95A	NONSYN	283	285	GGC	354	356	GCC	29;29;29	G;C;C	17;17;17	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	300	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3053	18.6	1	SNP	p	S91F	1	.	.	271	273	TTC	342	344	TTC	28;28;28	T;T;C	16;17;17	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_K_01388	mtrR.WHO_K_01388	1	1	27	102	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1263	15.2	1	SNP	p	G45D	1	.	.	133	135	GAC	489	491	GAC	27;27;27	G;A;C	15;15;16	mtrR.WHO_K_01388:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	76	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	924	14.5	0	.	n	.	0	A197.	DEL	197	197	A	704	704	A	37	A	21	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	312	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2586	21.5	1	SNP	p	D86N	0	.	.	256	258	GAC	411	413	GAC	24;24;24	G;A;C	14;12;13	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	312	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2586	21.5	1	SNP	p	R87W	0	.	.	259	261	CGT	414	416	CGT	24;24;25	C;G;T	14;14;13	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	312	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2586	21.5	1	SNP	p	R87I	0	.	.	259	261	CGT	414	416	CGT	24;24;25	C;G;T	14;14;13	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	312	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2586	21.5	1	SNP	p	S87R	1	.	.	259	261	CGT	414	416	CGT	24;24;25	C;G;T	14;14;13	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	312	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2586	21.5	1	SNP	p	S88P	0	.	.	262	264	TCC	417	419	TCC	25;24;24	T;C;C	13;14;15	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	244	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2782	16.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1443	1445	GGC	12;12;12	G;G;C	7;7;7	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.002	penA.2.002	1	1	27	248	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2195	19.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1193	1195	GCA	31;31;34	G;C;A	19;19;20	penA.2.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	248	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2195	19.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1196	1198	ATC	35;35;35	A;T;C	21;21;21	penA.2.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	248	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2195	19.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1208	1210	GTG	31;31;31	G;T;G	18;20;19	penA.2.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	248	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2195	19.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1208	1210	GTG	31;31;31	G;T;G	18;20;19	penA.2.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	248	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2195	19.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1712	1714	ACC	18;18;18	A;C;C	9;11;11	penA.2.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	248	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2195	19.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1766	1768	GCG	12;12;12	G;C;G	7;7;7	penA.2.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	248	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2195	19.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1766	1768	GCG	12;12;12	G;C;G	7;7;7	penA.2.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	248	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2195	19.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1889	1891	GGC	8;8;8	G;G;C	4;4;4	penA.2.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	248	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2195	19.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1898	1900	GGC	8;8;8	G;G;C	4;5;4	penA.2.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.002	penA.2.002	1	1	27	248	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2195	19.8	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1916	1918	CCG	9;9;9	C;C;G	4;4;4	penA.2.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	512	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2828	31.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1492	1494	CCG	18;18;18	C;C;G	10;12;10	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	124	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1504	14.9	0	.	p	.	0	S22G	NONSYN	64	66	AGC	253	255	GGC	13;13;14	G;G;C	8;9;9	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	124	porA	1146	1146	99.56	porA.l6.c4.ctg.1	1504	14.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	435	435	C	12	C	6	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	232	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	1727	24.6	0	.	p	.	0	A26T	NONSYN	76	78	GCC	408	410	ACC	20;20;18	A;C;C	15;15;14	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	232	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	1727	24.6	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	690	692	AAG	25;25;24	A;A;G	14;14;14	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	232	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	1727	24.6	1	SNP	p	D121N	0	.	.	361	363	GAC	693	695	GAC	24;24;24	G;A;C	13;14;12	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	232	porB1b	1047	1047	99.52	porB1b.l15.c4.ctg.1	1727	24.6	1	SNP	p	A121D	1	.	.	361	363	GAC	693	695	GAC	24;24;24	G;A;C	13;14;12	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	786	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4852	30.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	78	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1121	13.7	1	SNP	p	V57M	1	.	.	169	171	ATG	518	520	ATG	26;26;28	A;T;G	15;15;16	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	27	2220	tetM	1920	1920	100.0	tetM.l15.c4.ctg.1	2296	169.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Tetracycline resistance
